179 related articles for article (PubMed ID: 19528216)
21. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia.
Martiney JA; Sherry B; Metz CN; Espinoza M; Ferrer AS; Calandra T; Broxmeyer HE; Bucala R
Infect Immun; 2000 Apr; 68(4):2259-67. PubMed ID: 10722628
[TBL] [Abstract][Full Text] [Related]
22. Increased circulating interleukin (IL)-23 in children with malarial anemia: in vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10.
Ong'echa JM; Remo AM; Kristoff J; Hittner JB; Were T; Ouma C; Otieno RO; Vulule JM; Keller CC; Awandare GA; Perkins DJ
Clin Immunol; 2008 Feb; 126(2):211-21. PubMed ID: 17945537
[TBL] [Abstract][Full Text] [Related]
23. Distinct mechanisms of inadequate erythropoiesis induced by tumor necrosis factor alpha or malarial pigment.
Lamikanra AA; Merryweather-Clarke AT; Tipping AJ; Roberts DJ
PLoS One; 2015; 10(3):e0119836. PubMed ID: 25781011
[TBL] [Abstract][Full Text] [Related]
24. Hemolysis is associated with low reticulocyte production index and predicts blood transfusion in severe malarial anemia.
Fendel R; Brandts C; Rudat A; Kreidenweiss A; Steur C; Appelmann I; Ruehe B; Schröder P; Berdel WE; Kremsner PG; Mordmüller B
PLoS One; 2010 Apr; 5(4):e10038. PubMed ID: 20386613
[TBL] [Abstract][Full Text] [Related]
25. Clinical predictors of severe malarial anaemia in a holoendemic Plasmodium falciparum transmission area.
Novelli EM; Hittner JB; Davenport GC; Ouma C; Were T; Obaro S; Kaplan S; Ong'echa JM; Perkins DJ
Br J Haematol; 2010 Jun; 149(5):711-21. PubMed ID: 20408849
[TBL] [Abstract][Full Text] [Related]
26. Molecular structure, expression, and functional role of Clec11a in skeletal biology and cancers.
Wang M; Guo J; Zhang L; Kuek V; Xu J; Zou J
J Cell Physiol; 2020 Oct; 235(10):6357-6365. PubMed ID: 32003015
[TBL] [Abstract][Full Text] [Related]
27. Whole Blood Transfusion for Severe Malarial Anemia in a High Plasmodium falciparum Transmission Setting.
Ippolito MM; Kabuya JB; Hauser M; Kamavu LK; Banda PM; Yanek LR; Malik R; Mulenga M; Bailey JA; Chongwe G; Louis TA; Shapiro TA; Moss WJ;
Clin Infect Dis; 2022 Nov; 75(11):1893-1902. PubMed ID: 35439307
[TBL] [Abstract][Full Text] [Related]
28. Human NCR3 gene variants rs2736191 and rs11575837 alter longitudinal risk for development of pediatric malaria episodes and severe malarial anemia.
Onyango CO; Cheng Q; Munde EO; Raballah E; Anyona SB; McMahon BH; Lambert CG; Onyango PO; Schneider KA; Perkins DJ; Ouma C
BMC Genomics; 2023 Sep; 24(1):542. PubMed ID: 37704951
[TBL] [Abstract][Full Text] [Related]
29. Integrated OMICS platforms identify LAIR1 genetic variants as novel predictors of cross-sectional and longitudinal susceptibility to severe malaria and all-cause mortality in Kenyan children.
Achieng AO; Hengartner NW; Raballah E; Cheng Q; Anyona SB; Lauve N; Guyah B; Foo-Hurwitz I; Ong'echa JM; McMahon BH; Ouma C; Lambert CG; Perkins DJ
EBioMedicine; 2019 Jul; 45():290-302. PubMed ID: 31278068
[TBL] [Abstract][Full Text] [Related]
30. Plasma biomarkers of hemoglobin loss in Plasmodium falciparum-infected children identified by quantitative proteomics.
Mahamar A; Gonzales Hurtado PA; Morrison R; Boone R; Attaher O; Diarra BS; Gaoussou S; Issiaka D; Dicko A; Duffy PE; Fried M
Blood; 2022 Apr; 139(15):2361-2376. PubMed ID: 34871370
[TBL] [Abstract][Full Text] [Related]
31. Interleukin (IL)-13 promoter polymorphisms (-7402 T/G and -4729G/A) condition susceptibility to pediatric severe malarial anemia but not circulating IL-13 levels.
Okeyo WA; Munde EO; Okumu W; Raballah E; Anyona SB; Vulule JM; Ong'echa JM; Perkins DJ; Ouma C
BMC Immunol; 2013 Mar; 14():15. PubMed ID: 23521898
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya.
Zhang L; Prather D; Vanden Eng J; Crawford S; Kariuki S; ter Kuile F; Terlouw D; Nahlen B; Lal AA; Slutsker L; Udhayakumar V; Shi YP
Malar J; 2010 Mar; 9():87. PubMed ID: 20350312
[TBL] [Abstract][Full Text] [Related]
33. Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality.
Anyona SB; Kempaiah P; Raballah E; Ouma C; Were T; Davenport GC; Konah SN; Vulule JM; Hittner JB; Gichuki CW; Ong'echa JM; Perkins DJ
Infect Immun; 2011 Dec; 79(12):4923-32. PubMed ID: 21969001
[TBL] [Abstract][Full Text] [Related]
34. Malaria, erythrocytic infection, and anemia.
Haldar K; Mohandas N
Hematology Am Soc Hematol Educ Program; 2009; ():87-93. PubMed ID: 20008186
[TBL] [Abstract][Full Text] [Related]
35. Reduced interferon (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality.
Kempaiah P; Anyona SB; Raballah E; Davenport GC; Were T; Hittner JB; Ong'echa JM; Perkins DJ
Hum Genet; 2012 Aug; 131(8):1375-91. PubMed ID: 22570109
[TBL] [Abstract][Full Text] [Related]
36. Ingestion of hemozoin by peripheral blood mononuclear cells alters temporal gene expression of ubiquitination processes.
Anyona SB; Cheng Q; Raballah E; Hurwitz I; Lambert CG; McMahon BH; Ouma C; Perkins DJ
Biochem Biophys Rep; 2022 Mar; 29():101207. PubMed ID: 35071802
[No Abstract] [Full Text] [Related]
37. Hemozoin- and 4-hydroxynonenal-mediated inhibition of erythropoiesis. Possible role in malarial dyserythropoiesis and anemia.
Giribaldi G; Ulliers D; Schwarzer E; Roberts I; Piacibello W; Arese P
Haematologica; 2004 Apr; 89(4):492-3. PubMed ID: 15075084
[TBL] [Abstract][Full Text] [Related]
38. Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells.
Keller CC; Kremsner PG; Hittner JB; Misukonis MA; Weinberg JB; Perkins DJ
Infect Immun; 2004 Aug; 72(8):4868-73. PubMed ID: 15271950
[TBL] [Abstract][Full Text] [Related]
39. Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 gene expression via an interleukin-10-independent mechanism.
Keller CC; Hittner JB; Nti BK; Weinberg JB; Kremsner PG; Perkins DJ
Mol Med; 2004; 10(1-6):45-54. PubMed ID: 15502882
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of circulating levels of stem cell growth factor beta (SCGF beta) in patients with Chagas' disease and idiopathic dilated cardiomyopathy.
Wang Y; Khan A; Heringer-Walther S; Schultheiss HP; Moreira Mda C; Walther T
Cytokine; 2013 Mar; 61(3):728-31. PubMed ID: 23357302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
